Cigna Investments Inc. New raised its position in MSCI Inc (NYSE:MSCI) by 108.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 8,036 shares of the technology company’s stock after buying an additional 4,182 shares during the period. Cigna Investments Inc. New’s holdings in MSCI were worth $828,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in MSCI. Van ECK Associates Corp increased its position in shares of MSCI by 6.8% in the first quarter. Van ECK Associates Corp now owns 1,494 shares of the technology company’s stock worth $145,000 after buying an additional 95 shares during the last quarter. OLD Mutual Customised Solutions Proprietary Ltd. increased its position in shares of MSCI by 115.0% in the first quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 1,505 shares of the technology company’s stock worth $146,000 after buying an additional 805 shares during the last quarter. Pacer Advisors Inc. increased its position in shares of MSCI by 2.9% in the first quarter. Pacer Advisors Inc. now owns 1,639 shares of the technology company’s stock worth $159,000 after buying an additional 46 shares during the last quarter. Copper Rock Capital Partners LLC increased its position in shares of MSCI by 309.1% in the second quarter. Copper Rock Capital Partners LLC now owns 2,078 shares of the technology company’s stock worth $164,000 after buying an additional 1,570 shares during the last quarter. Finally, Two Sigma Securities LLC acquired a new position in shares of MSCI during the first quarter worth $203,000. Hedge funds and other institutional investors own 95.18% of the company’s stock.

MSCI Inc (MSCI) opened at 107.13 on Friday. The company has a 50-day moving average price of $107.00 and a 200 day moving average price of $99.55. MSCI Inc has a 1-year low of $76.52 and a 1-year high of $113.38. The stock has a market cap of $9.65 billion, a P/E ratio of 34.69 and a beta of 1.04.

MSCI (NYSE:MSCI) last posted its earnings results on Thursday, August 3rd. The technology company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05. MSCI had a net margin of 24.01% and a return on equity of 87.11%. The business had revenue of $316.08 million during the quarter, compared to the consensus estimate of $314.03 million. During the same quarter in the previous year, the firm posted $0.77 EPS. The firm’s revenue was up 8.8% on a year-over-year basis. Equities analysts expect that MSCI Inc will post $3.80 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, August 31st. Shareholders of record on Friday, August 18th will be given a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date is Wednesday, August 16th. This is an increase from MSCI’s previous quarterly dividend of $0.28. MSCI’s payout ratio is 36.13%.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another site, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/12/msci-inc-nysemsci-shares-bought-by-cigna-investments-inc-new.html.

A number of brokerages have recently weighed in on MSCI. BidaskClub downgraded MSCI from a “strong-buy” rating to a “buy” rating in a research note on Thursday, June 22nd. Zacks Investment Research upgraded MSCI from a “hold” rating to a “buy” rating and set a $115.00 target price on the stock in a research note on Thursday, July 6th. Credit Suisse Group cut their target price on MSCI from $105.00 to $94.00 and set an “outperform” rating on the stock in a research note on Friday, May 5th. UBS AG boosted their target price on MSCI from $115.00 to $125.00 and gave the stock a “buy” rating in a research note on Friday, August 4th. Finally, Morgan Stanley restated an “equal weight” rating and issued a $97.00 target price (down previously from $98.00) on shares of MSCI in a research note on Tuesday, July 18th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $106.29.

In other MSCI news, COO Cd Baer Pettit sold 2,083 shares of MSCI stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $111.16, for a total value of $231,546.28. Following the completion of the sale, the chief operating officer now owns 178,266 shares of the company’s stock, valued at approximately $19,816,048.56. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In the last ninety days, insiders sold 6,249 shares of company stock valued at $663,581. 2.26% of the stock is currently owned by insiders.

About MSCI

MSCI Inc offers products and services to support the needs of institutional investors throughout their investment processes. Its segments include Index, Analytics and All Other segment. All Other segment comprises environmental, social and governance (ESG) and Real Estate segments. Its indexes are used in various areas of the investment process, including index-linked product creation and performance benchmarking, as well as portfolio construction and rebalancing, and asset allocation.

Want to see what other hedge funds are holding MSCI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MSCI Inc (NYSE:MSCI).

Institutional Ownership by Quarter for MSCI (NYSE:MSCI)

Receive News & Ratings for MSCI Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MSCI Inc and related companies with MarketBeat.com's FREE daily email newsletter.